Specialists in infectious disease are protesting a gigantic overnight increase in the price of a 62-year-old drug that is the standard of care for treating a life-threatening parasitic infection.
The drug, called Daraprim, was acquired in August by Turing Pharmaceuticals, a start-up run by a former hedge fund manager. Turing immediately raised the price to $750 a tablet f… http://mylifeisworthit.org/blog/2015/09/drug-goes-1350-tablet-750-overnight/
New immune-boosting drugs like Merck ’s Keytruda and Bristol-Myers Squibb BMY +1.61%’s Opdivo are changing the game for cancer patients, but their six-figure-per-year price tags have raised eyebrows among payers worldwide. Those cost concerns…
Earlier this year, Curis partnered with India-based Aurigene to develop several drugs, including one with a similar mechanism of action to Keytruda (pembrolizumab) and Opdivo (n… http://mylifeisworthit.org/blog/2015/09/one-biotech-ceos-plan-slash-cost-cancer-immunotherapy/